🔎 Trials Near Me

Home › Geographic Atrophy › Arizona

Pag-aaral pangklinika para sa Geographic Atrophy sa Arizona

5 pag-aaral para sa Geographic Atrophy ang naghahanap ng mga kalahok sa mga site sa Arizona.

Mga Lungsod sa Arizona

Opisyal na teksto ng pag-aaral (English)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Retina Associates Southwest PC, Tucson
Nagre-recruitPhase 2/3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06635148

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Associated Retina Consultants - PHX, Gilbert
  • Associated Retina Consultants, Phoenix
Nagre-recruitPhase 1/2
Edad 55 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07029945

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  • Associated Retina Consultants - Peoria- Site Number : 8400011, Peoria
  • Retina Macula Institute of Arizona- Site Number : 8400028, Scottsdale
Nagre-recruitPhase 1/2
Edad 60 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07215234

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Barnet Dulaney Perkins Eye Center-Ophthamalogy, Chandler
  • Barnet Dulaney Perkins Eye Center, Phoenix
  • Associated Retina Consultants, Phoenix
  • at 3 pa
Nagre-recruitPhase 3
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Associated Retina Consultants, Gilbert
  • Associated Retina Consultants, Phoenix
Nagre-recruitPhase 2
Edad 55 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06659445

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.